Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer | MicrobiomeTrials← Back to trialsNCT07057791
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-03-30Est. Completion: 2027-12
Enrollment target: 60 participants Locations- University of Miami, Miami, Florida, United States
- Rutgers Cancer Institute, New Brunswick, New Jersey, United States
- Montefiore Medical Center- Montefiore Medical Park, The Bronx, New York, United States
- Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
- Guthrie, Sayre, Pennsylvania, United States
- Universtiy of Virginia, Charlottesville, Virginia, United States
- Aspirus Cancer Center Wausau, Wausau, Wisconsin, United States
Other microbiome trials you might be interested in
Non Small Cell Lung Cancer
The purpose of this study, known as DISCERN, is to compare two different treatments for a type of lung cancer called non…
Birmingham, United StatesEst. completion Apr 27, 2027
Extensive-Stage Small Cell Lung CancerExtrapulmonary Neuroendocrine CarcinomaRecurrent or RefractorySolid Tumors
Background:
Small cell lung cancer (SCLC) is the deadliest form of lung cancer. Extrapulmonary neuroendocrine cancer (E…
Bethesda, United StatesEst. completion Jan 30, 2030